Clinical Trial Update: Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating alternative regimens for metastatic colorectal cancer; the study comparing Lohp plus 5-FU/Lv with Bevacizumab versus CPT-11 plus 5-FU/L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• LOHP
• Leucovorin (folinic acid)

Snippet

Sponsor: University Hospital of Crete | Conditions: Colorectal Cancer | Phase 2 | Status: TERMINATED